Contact: Kara Gavin, [email protected], 734-764-2220

Experts meet to survey future of bone marrow transplants

From stem cells to cord blood, bone marrow transplant experts from the U.S. and Europe will discuss the future of their field at a symposium at the University of Michigan on Friday, October 22.

The meeting, which will focus on immunological aspects of bone marrow transplantation, is sponsored by the U-M Comprehensive Cancer Center and directed by James Ferrara, M.D., Director of the U-M Adult and Pediatric Blood and Marrow Transplant Program

Bone marrow transplantation is a treatment for many diseases in both children and adults. Among these are certain blood cancers such as leukemia and lymphoma; some solid tumors; blood diseases such as aplastic anemia; some immune diseases; and serious genetic disorders.

The symposium will feature an overview of recent advances in the area by physicians and research scientists from the U-M, the University of Minnesota, the University of Washington, and the Ludwigs Maximilians University in Munich, Germany.

Talks will address strategies for tumor vaccines, cord blood transplants, stem cell transplantation, donor leukocyte transfusions, and quality of life for bone marrow transplant recipients.

MEDIA CONTACT
Register for reporter access to contact details